|
Variables
|
Before
|
3 months
|
6 months
|
|---|
|
Immunological and inflammatory parameters
| | | |
|
NK cell activity; E/T ratio 10:1 (%)
|
10.2 ± 8.8
|
10.5 ± 9.9
|
12.6 ± 12.4*
|
|
E/T ratio 20:1 (%)
|
17.3 ± 14.1
|
17.4 ± 15.3
|
20.8 ± 17.7**
|
|
CD4/CD8 ratio
|
2.2 ± 3.3
|
2.0 ± 2.2
|
2.1 ± 2.3
|
|
IgG (mg/dL)
|
1460 ± 410
|
1430 ± 350
|
1490 ± 400
|
|
IL-6 (pg/mL)
|
5.2 ± 2.5
|
7.8 ± 5.1*
|
7.7 ± 5.0
|
|
sIL-2R (U/mL)
|
1311 ± 1020
|
1103 ± 448
|
1233 ± 498
|
|
C-reactive protein (mg/dL)
|
0.6 ± 1.0
|
0.6 ± 0.9
|
1.0 ± 1.8
|
|
Trace elements
| | | |
|
Selenium (μg/L)
|
60.4 ± 13.9
|
63.5 ± 17.0
|
52.4 ± 12.2*
|
|
Zinc (μg/dL)
|
48.5 ± 8.6
|
52.3 ± 10.1
|
51.7 ± 9.6
|
|
Copper (μg/dL)
|
94.0 ± 19.1
|
90.8 ± 21.9
|
91.4 ± 23.0
|
-
NK cell natural killer cell, E/T ratio effector cells/target cells ratio, CD cluster of differentiation, IgG immunoglobulin G, IL-6 interleukin-6, sIL-2R soluble interleukin-2 receptor, SD standard deviation
- *p < 0.05, **p < 0.01 vs. before treatment. Data, means ± SD
